Related Experiment Videos
Results of treatment of head and neck carcinoma with high dose methotrexate
R Bell1, J R Sullivan, W B Fleming
1Department of Haemato-Oncology, Royal Melbourne Hospital, Victoria, Australia.
Clinical and Experimental Pharmacology & Physiology. Supplement
|January 1, 1979
Abstract:
Forty four patients with squamous cell carcinoma of the head and neck from a variety of primary sites were treated with high dose methotrexate with folinic acid rescue from 1975 to 1977. The overall response rate was 66%. Response duration was short with a mean of 16 weeks. The usefulness of this technique in the treatment of head and neck cancer is discussed.